Revenue
2019
2020
2021
2022
2023
2024
2025
2026
HAEMONETICS CORP (HAE)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2019
2020
2021
2022
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993.2M | $870.5M | $988.5M | $967.6M | $903.9M | $886.1M | — | $910.4M | $938.5M | $892.0M | $727.8M | $676.7M | $645.4M | — |
| Gross profit | $787.6M | $749.0M | $691.5M | $615.1M | $505.5M | $397.8M | $484.5M | $417.5M | $411.9M | $378.5M | $405.9M | $434.4M | $468.4M | $428.1M | $369.2M | $355.2M | $337.5M | $308.2M |
| Research & development | $59.8M | $62.7M | $54.4M | $50.1M | $46.8M | $32.9M | $30.9M | $35.7M | $39.2M | $37.6M | $45.0M | $54.2M | $54.2M | $44.4M | $36.8M | $32.7M | $26.4M | $23.9M |
| Operating expenses | $630.9M | $527.1M | $526.7M | $459.1M | $424.8M | $308.1M | $381.2M | $334.0M | $355.8M | $397.9M | $449.9M | $393.9M | $421.9M | $371.7M | $280.5M | $244.7M | $254.2M | $222.6M |
| Operating income | $156.7M | $221.8M | $164.9M | $156.0M | $80.8M | $89.7M | $103.4M | $83.5M | $56.2M | −$19.4M | −$43.9M | $40.5M | $46.4M | $56.4M | $88.8M | $110.5M | $83.3M | $85.6M |
| EBITDAderived | $268.5M | $337.4M | $262.1M | $249.3M | $178.5M | $174.0M | $213.6M | $193.0M | $145.4M | $70.4M | $46.0M | $126.6M | $128.2M | $121.9M | $138.7M | $158.7M | $126.5M | $122.0M |
| Net income | $97.3M | $167.7M | $117.6M | $115.4M | $43.4M | $79.5M | $76.5M | $55.0M | $45.6M | −$26.3M | −$55.6M | $16.9M | $35.1M | $38.8M | $66.9M | $80.0M | $58.4M | $59.3M |
| Basic EPSper diluted share | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | -$0.51 | -$1.09 | $0.33 | $0.68 | $0.76 | $1.32 | $1.59 | $2.29 | $2.34 |
| Diluted EPSper diluted share | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | -$0.51 | -$1.09 | $0.32 | $0.67 | $0.74 | $1.30 | $1.56 | $2.24 | $2.27 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 10, 2025Form 4 | KROLL MARK WDirector | BuyCommon Stock | 1.4K | $70.56 | $98.8K | 24.8K |
| Jul 26, 2024Form 4 · 10b5-1 | Strong Stewart WPresident, Global Hospital | SellCommon Stock | 4.3K | $91.15 | $393.0K | 18.2K |
| Jul 12, 2024Form 4 · 10b5-1 | Lingamneni AnilaEVP, Chief Technology Officer | SellCommon Stock | 79 | $90.00 | $7.1K | 21.3K |
| Jul 11, 2024Form 4 · 10b5-1 | Lingamneni AnilaEVP, Chief Technology Officer | SellCommon Stock | 2.1K | $90.00 | $192.2K | 21.4K |